Dr. Reddy's Drops Patent Challenge To Glaxo's Zofran
Indian generic drug maker Dr. Reddy's Laboratories has withdrawn its challenge to the main U.S. patent on GlaxoSmithKline anti-nausea drug Zofran, the U.K. drug maker said on Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article